PT83179B - Processo para a preparacao de carbinois aril-piperidinicos - Google Patents

Processo para a preparacao de carbinois aril-piperidinicos

Info

Publication number
PT83179B
PT83179B PT83179A PT8317986A PT83179B PT 83179 B PT83179 B PT 83179B PT 83179 A PT83179 A PT 83179A PT 8317986 A PT8317986 A PT 8317986A PT 83179 B PT83179 B PT 83179B
Authority
PT
Portugal
Prior art keywords
piperidinicos
carbinois
aril
preparation
carbinois aril
Prior art date
Application number
PT83179A
Other languages
English (en)
Other versions
PT83179A (en
Inventor
Roger Thomas Martin
Erol Ali Faruk
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858520153A external-priority patent/GB8520153D0/en
Priority claimed from GB868612579A external-priority patent/GB8612579D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of PT83179A publication Critical patent/PT83179A/pt
Publication of PT83179B publication Critical patent/PT83179B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT83179A 1985-08-10 1986-08-08 Processo para a preparacao de carbinois aril-piperidinicos PT83179B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858520153A GB8520153D0 (en) 1985-08-10 1985-08-10 Chemical process
GB868612579A GB8612579D0 (en) 1986-05-23 1986-05-23 Chemical process

Publications (2)

Publication Number Publication Date
PT83179A PT83179A (en) 1986-09-01
PT83179B true PT83179B (pt) 1989-03-30

Family

ID=26289644

Family Applications (1)

Application Number Title Priority Date Filing Date
PT83179A PT83179B (pt) 1985-08-10 1986-08-08 Processo para a preparacao de carbinois aril-piperidinicos

Country Status (17)

Country Link
US (1) US4902801A (pt)
EP (1) EP0223334B1 (pt)
JP (2) JPH0696551B2 (pt)
AU (1) AU582456B2 (pt)
BG (1) BG61319B2 (pt)
CA (1) CA1310649C (pt)
CY (1) CY1708A (pt)
DE (1) DE3680184D1 (pt)
DK (1) DK169730B1 (pt)
ES (2) ES2000603A6 (pt)
GR (1) GR862102B (pt)
HK (1) HK69793A (pt)
IE (1) IE58831B1 (pt)
MX (1) MX171822B (pt)
NZ (1) NZ217141A (pt)
PT (1) PT83179B (pt)
SG (1) SG27793G (pt)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
DK588289D0 (da) * 1989-11-22 1989-11-22 Ferrosan As Ny heterocyklisk kemi
JPH04288059A (ja) * 1991-03-14 1992-10-13 Nippon Paint Co Ltd 複素環化合物及びその製造法
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
GB9305175D0 (en) * 1993-03-13 1993-04-28 Smithkline Beecham Plc Novel process
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US6444190B2 (en) 1995-08-03 2002-09-03 Fmc Corporation Reduction compositions and processes for making the same
EP0789573A4 (en) * 1995-08-03 1998-04-29 Fmc Corp REDUCTIONS USING HYDRIDES
ES2121685B1 (es) * 1996-04-10 1999-09-16 Vita Invest Sa Procedimiento para la obtencion de (+)-trans-4(4-fluoro-fenil)-3-hidroximetil-1-metilpiperidina.
JP3446468B2 (ja) 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
US5936090A (en) * 1996-05-24 1999-08-10 Fmc Corporation Processes for the reduction of imide ester functionality
EP1384720A1 (en) * 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Process for drying paroxetine hydrochloride
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
AU4651497A (en) * 1996-09-24 1998-04-17 Fmc Corporation Novel reduction compositions and processes for making the same
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process
CA2284732C (en) * 1997-04-07 2008-06-17 Georgetown University Analogs of cocaine
GB9710004D0 (en) * 1997-05-17 1997-07-09 Knoll Ag Chemical process
ID24383A (id) 1997-05-29 2000-07-13 Smithkline Beecham Corp Proses baru
EP1078925A1 (en) 1997-06-10 2001-02-28 Synthon B.V. 4-Phenylpiperidine compounds
DE69910691T2 (de) * 1998-06-29 2004-07-08 Sumika Fine Chemical Co. Ltd. L-Tartrate von Trans-(-)-4-(4-Fluorphenyl)-3-Hydroxymethyl-Piperidin Verbindungen und Verfahren zu ihrer Herstellung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
WO2000026187A1 (en) * 1998-11-02 2000-05-11 Synthon B.V. Process for producing 4-arylpiperidine-3-carbinols and related compounds
GB9915303D0 (en) * 1999-06-30 1999-09-01 Smithkline Beecham Plc Novel process
IT1313702B1 (it) * 1999-08-02 2002-09-09 Chemi Spa Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine.
GB9920147D0 (en) * 1999-08-25 1999-10-27 Smithkline Beecham Plc Novel process
GB9924855D0 (en) * 1999-10-20 1999-12-22 Smithkline Beecham Plc Novel processes
GB9924882D0 (en) * 1999-10-20 1999-12-22 Smithkline Beecham Plc Novel process
AU1037701A (en) * 1999-10-20 2001-04-30 Smithkline Beecham Plc Process for the preparation of 4-(fluorophenyl)piperidine esters
GB9930577D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Novel process
CZ20023694A3 (cs) * 2000-05-12 2003-05-14 Synthon B. V. Tosylátové soli 4-(p-fluorfenyl)-piperidin-3-methanolů
US6833458B2 (en) 2000-06-05 2004-12-21 Development Center For Biotechnology Practical syntheses of chiral trans-3, 4-disubstituted piperidines and the intermediates
AU2001211337A1 (en) * 2000-10-06 2002-04-15 Smithkline Beecham Plc Process for the preparation of aryl-piperidine carbinols and intermediates thereof
DK1347960T3 (da) * 2001-01-04 2005-03-21 Ferrer Int Fremgangsmåde til fremstilling af (+/-) trans-4-p-fluorphenyl-3-hydromethyl-1-methylpiperidin
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
AU2002232017A1 (en) * 2001-02-24 2002-09-12 Spurcourt Limited Process of preparing paroxetine and intermediates for use therein
CA2457382A1 (en) * 2001-06-13 2002-12-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of paroxetine substantially free of alkoxy impurities
KR100477048B1 (ko) * 2002-07-05 2005-03-17 임광민 피페리딘 화합물의 새로운 제조방법
WO2004043921A1 (en) * 2002-11-11 2004-05-27 Natco Pharma Limited Novel process for the preparation of 4-aryl-3-hydroxymethyl-1-methylpiperidines.
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
CN101205211B (zh) * 2006-12-19 2011-12-14 北京德众万全药物技术开发有限公司 一种盐酸帕罗西汀重要中间体的制备方法
WO2015071831A1 (en) * 2013-11-18 2015-05-21 Piramal Enterprises Limited An improved process for minimising the formation of dehalogenated byproducts
CN104262255A (zh) * 2014-09-22 2015-01-07 四川大学 一种不对称催化合成γ-硝基吡唑酰胺化合物的方法
CN104402800A (zh) * 2014-12-02 2015-03-11 千辉药业（安徽）有限责任公司 一种反式-4-(4-氟苯基)-3-羟甲基-1-甲基哌啶的制备方法
WO2022269643A1 (en) * 2021-06-25 2022-12-29 Vihita Chem Private Limited An improved process for the preparation of intermediate for paroxetine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE625656A (pt) * 1961-12-05
NL125654C (pt) * 1963-12-17 1900-01-01
US3666746A (en) * 1969-06-25 1972-05-30 Gaf Corp Pyrrolidonylphenyl azo dyestuffs
US3681327A (en) * 1970-07-01 1972-08-01 Exxon Research Engineering Co N-methylenethiophosphate derivatives of 1,3-thiazines and 1,4-thiazanes
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US3947460A (en) * 1974-06-27 1976-03-30 Sandoz, Inc. 5-Hydroxy-5-substituted phenyl-pyrrolidones and piperidinones
EP0047516B1 (en) * 1980-09-04 1984-01-04 Toray Industries, Inc. Propylamine derivative and process of manufacturing the same
US4585777A (en) * 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT

Also Published As

Publication number Publication date
DK380986A (da) 1987-02-11
MX171822B (es) 1993-11-17
IE58831B1 (en) 1993-11-17
US4902801A (en) 1990-02-20
AU582456B2 (en) 1989-03-23
BG61319B2 (bg) 1997-05-30
SG27793G (en) 1993-05-21
NZ217141A (en) 1989-06-28
DE3680184D1 (de) 1991-08-14
CY1708A (en) 1994-01-14
JPH08809B2 (ja) 1996-01-10
HK69793A (en) 1993-07-30
DK169730B1 (da) 1995-01-30
DK380986D0 (da) 1986-08-08
AU6101286A (en) 1987-02-12
EP0223334B1 (en) 1991-07-10
ES2000603A6 (es) 1988-03-01
JPS6239566A (ja) 1987-02-20
GR862102B (en) 1986-12-30
ES2005745A6 (es) 1989-03-16
PT83179A (en) 1986-09-01
JPH0696551B2 (ja) 1994-11-30
EP0223334A1 (en) 1987-05-27
CA1310649C (en) 1992-11-24
JPH07138228A (ja) 1995-05-30
IE862135L (en) 1987-02-10

Similar Documents

Publication Publication Date Title
PT83179B (pt) Processo para a preparacao de carbinois aril-piperidinicos
PT81859B (pt) Processo para a preparacao de derivados de tiazolidinodionas
PT83085B (pt) Processo para a preparacao de eteres de fenilo
BR8605084A (pt) Processo para a preparacao de diaminocompostos aromaticos
PT82989B (pt) Processo para a preparacao de antibioticos beta-lactamicos
PT83152B (pt) Processo para a preparacao de compostos di-t-butilfenoicos
PT82062B (pt) Processo para a preparacao de compostos piridinilimidazolidinona
BR8601962A (pt) Processo para a preparacao de compostos
PT83344A (pt) Processo para a preparacao de ypsilon-carbolinas antipsicoticas
BR8707028A (pt) Processo para a preparacao de mercaptometilfenois
PT82678B (pt) Processo para a preparacao de compostos de cinolina
PT84072B (pt) Processo para a preparacao de esteroides aminoglicosidicos
PT83074B (pt) Processo para a preparacao de produtos de solvatacao de 3-propenil-cefalosporina
BR8501588A (pt) Processo para a preparacao de poliisocianatos
PT82383B (pt) Processo para a preparacao de epipodofilotoxina e compostos afins
PT82245B (pt) Processo para a preparacao de 2-amino-6-cloropurina
BR8502305A (pt) Processo para a preparacao de organopol issiloxanas organofuncionais
BR8505989A (pt) Processo para a preparacao de amino-4-difenilaminas
BR8706408A (pt) Processo para a preparacao de aldeidos
BR8501134A (pt) Processo para a preparacao de gliciditeres
PT83154B (pt) Processo para a preparacao de quinolizino-sulfonamidas
BR8602094A (pt) Processo para a preparacao de benzotiazolsulfenamidas
PT82323B (pt) Processo para a preparacao de alcanoilanilidas
PT80634B (pt) Processo para a preparacao de naftoxacinas
BR8600378A (pt) Processo para a preparacao de vinilaminossilanos